Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Archives of Biochemistry and Biophysics|May 8, 2020
Thermodynamic dissection of the interface between HIV-1 gp41 heptad repeats reveals cooperative interactions and allosteric effectsSamuel Jurado, Mario Cano-Muñoz, Daniel Polo-Megías, et al.International Journal of Molecular Sciences|December 23, 2022
Exploring Highly Conserved Regions of SARS-CoV-2 Spike S2 Subunit as Targets for Fusion Inhibition Using Chimeric ProteinsDaniel Polo-Megías, Mario Cano-Muñoz, Alberto G Berruezo, et al.International Journal of Biological Macromolecules|February 14, 2024
Investigating vulnerability of the conserved SARS-CoV-2 spike's heptad repeat 2 as target for fusion inhibitors using chimeric miniproteinsDaniel Polo-Megías, Mario Cano-Muñoz, Alberto G Berruezo, et al.Journal of Molecular Biology|August 22, 2020
Probing Vulnerability of the gp41 C-Terminal Heptad Repeat as Target for Miniprotein HIV InhibitorsSamuel Jurado, Christiane Moog, Mario Cano-Muñoz, et al.Plants (Basel, Switzerland)|July 27, 2022
Fruit Phenolic and Triterpenic Composition of Progenies of Olea europaea subsp. cuspidata, an Interesting Phytochemical Source to Be Included in Olive Breeding ProgramsIrene Serrano-García, Lucía Olmo-García, Daniel Polo-Megías, et al.Protein Science : a Publication of the Protein Society|May 4, 2026
Investigating the role of a conserved hydrophobic pocket of gp41 in the anti-HIV activity of fusion inhibitorsDaniel Polo-Megías, Mario Cano-Muñoz, Laura Sánchez-Martínez, et al.International Journal of Biological Macromolecules|October 11, 2022
Novel chimeric proteins mimicking SARS-CoV-2 spike epitopes with broad inhibitory activityMario Cano-Muñoz, Daniel Polo-Megías, Ana Cámara-Artigas, et al.International Journal of Biological Macromolecules|April 16, 2025
Potent HIV-1 miniprotein inhibitors targeting highly conserved gp41 epitopesDaniel Polo-Megías, Mario Cano-Muñoz, Pierre Gantner, et al.International Journal of Biological Macromolecules|January 8, 2026
Neutralizing nanobodies against SARS-CoV-2 recognizing highly conserved epitopes at the Spike's S2 subunitDaniel Polo-Megías, Mario Cano-Muñoz, Philipp Trolese, et al.Pageof 1